fbpx
< All Topics
Print

SARS-CoV-2 seroprevalence among healthcare workers

Publication:

PLOS One | April 25th, 2022

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0266410https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0266410

Author(s):

Talia D. Wiggen, Bruno Bohn, Angela K. Ulrich, Steven D. Stovitz, Ali J. Strickland, Brianna M. Naumchik, Sara Walsh, Stephen Smith, Brett Baumgartner, Susan Kline, Stephanie Yendell, Craig Hedberg, Timothy J. Beebe, Ryan T. Demmer 

Quansys Products Used:

Q-Plex™ SARS-CoV-2 Human IgG (4-Plex)

Abstract:

Background

Monitoring COVID-19 infection risk among health care workers (HCWs) is a public health priority. We examined the seroprevalence of SARS-CoV-2 among HCWs following the fall infection surge in Minnesota, and before and after COVID-19 vaccination. Additionally, we assessed demographic and occupational risk factors for SARS-CoV-2 infection.

Methods

We conducted two rounds of seroprevalence testing among a cohort of HCWs: samples in round 1 were collected from 11/22/20–02/21/21 and in round 2 from 12/18/20–02/15/21. Demographic and occupational exposures assessed with logistic regression were age, sex, healthcare role and setting, and number of children in the household. The primary outcome was SARS-CoV-2 IgG seropositivity. A secondary outcome, SARS-CoV-2 infection, included both seropositivity and self-reported SARS-CoV-2 test positivity.

Results

In total, 459 HCWs were tested. 43/454 (9.47%) had a seropositive sample 1 and 75/423 (17.7%) had a seropositive sample 2. By time of sample 2 collection, 54% of participants had received at least one vaccine dose and seroprevalence was 13% among unvaccinated individuals. Relative to physicians, the odds of SARS-CoV-2 infection in other roles were increased (Nurse Practitioner: OR[95%CI] 1.93[0.57,6.53], Physician’s Assistant: 1.69[0.38,7.52], Nurse: 2.33[0.94,5.78], Paramedic/EMTs: 3.86[0.78,19.0], other: 1.68[0.58,4.85]). The workplace setting was associated with SARS-CoV-2 infection (p = 0.04). SARS-CoV-2 seroprevalence among HCWs reporting duties in the ICU vs. those working in an ambulatory clinic was elevated: OR[95%CI] 2.17[1.01,4.68].

Conclusions

SARS-CoV-2 seroprevalence in HCW increased during our study period which was consistent with community infection rates. HCW role and setting—particularly working in the ICU—is associated with higher risk for SARS-CoV-2 infection.

Previous Elimination of receptor binding by influenza hemagglutinin improves vaccine-induced immunity
Next A low dose adenovirus vectored vaccine expressing Schistosoma mansoni Cathepsin B protects from intestinal schistosomiasis in mice